Medical device company, Microbot Medical Inc., is making strides in the development of robotic endoluminal surgery devices designed for minimally invasive procedures. The pre-clinical company's proprietary ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies are focused on creating next-level solutions for the treatment of hydrocephalus and normal pressure hydrocephalus, endovascular interventional procedures, and more. Boasting 42 issued or allowed patents, along with 23 patent applications pending globally, Microbot Medical has positioned itself as a leading innovator in the medical device industry. The company has also secured a strategic collaboration agreement with Stryker Corporation, further underlining its commitment to technological co-development. Founded in 2010 and headquartered in Hingham, Massachusetts, Microbot Medical Inc. is poised for continued success in the rapidly evolving world of medical technology.
Microbot Medical Inc.'s ticker is MBOT
The company's shares trade on the NASDAQ stock exchange
They are based in Hingham, Massachusetts
There are 1-10 employees working at Microbot Medical Inc.
It is http://www.microbotmedical.com/
Microbot Medical Inc. is in the Healthcare sector
Microbot Medical Inc. is in the Medical Instruments & Supplies industry
The following five companies are Microbot Medical Inc.'s industry peers: